Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Schedule of Stock Option Activity (Details)

v3.23.1
Stock-Based Compensation - Schedule of Stock Option Activity (Details) - Stock Option - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Options    
Options outstanding, beginning balance (in shares) 684,000  
Granted (in shares) 228,000  
Exercised (in shares) 0  
Forfeited (in shares) (184,000)  
Options outstanding, ending balance (in shares) 728,000 684,000
Options exercisable (in shares) 167,000  
Weighted Average Exercise Price    
Weighted average exercise price, beginning balance (in USD per share) $ 8.82  
Granted (in USD per share) 6.46  
Exercised (in USD per share) 0  
Forfeited (in USD per share) 8.83  
Weighted average exercise price, ending balance (in USD per share) 8.08 $ 8.82
Options exercisable (in USD per share) $ 8.82  
Weighted Average Remaining Contractual Term    
Weighted Average Remaining Contractual Term 9 years 3 months 7 days
Options exercisable, Weighted average remaining contractual term 8 years 11 months 15 days  
Aggregate Intrinsic Value    
Aggregate intrinsic value $ 0
Options exercisable $ 0